Document is current

Article History

Accepted: 10 July 2024

First Online: 6 September 2024

Declarations

:

: The study was sponsored by Glaukos Corporation (Aliso Viejo, CA, USA). Glaukos participated in the design of the study, data management, analysis and interpretations, and the preparation, review, and approval of the manuscript.

: I. Paul Singh has received consulting fees from Allergan, Alcon, Bausch + Lomb, Glaukos, iStar Medical, New World Medical, Nova Eye, and Sight Sciences; and lecture fees from Allergan, Alcon, Bausch + Lomb, Glaukos, iStar Medical, New World Medical, Nova Eye, Sight Sciences, Thea and Viatris. John P. Berdahl has received consulting fees, has been a paid advisory board member or received fees for attending a meeting for AbbVie, Aerpio, Alcon, Aldeyra, Aurea Medical, Aurion Biotech/CorneaGen, Balance Ophthalmics, Bausch and Lomb, Dakota Lions Eye Bank, Elios Vision Inc., Equinox, Expert Opinion, Glaukos, Gore, Imprimis, Interfeen, iRenix, Iacta Pharmaceuticals, IVERIC bio, Inc., JNJ, Kala, Kedalion, MELT Pharmaceuticals, MicroOptx, New World Medical, Ocular Surgical Data, Ocular Therapeutix, Omega Ophthalmic, Orasis, Oyster Point, RxSight, Santen, Sight Sciences, Surface Inc., Tarsus, Tear Clear, Vertex Ventures, ViaLase, Vittamed, Vance Thompson Vision, Versea Biologics, Visionary Ventures, Visus and Zeiss; has received lecture fees (honoraria), travel fees or reimbursements when speaking for AbbVie, Alcon and Glaukos; has equity ownership/stock options of Aurion Biotech/CorneaGen, Balance Ophthalmics, Equinox, Expert Opinion, Interfeen, Ocular Surgical Data, Omega Ophthalmic, Surface Inc, Vance Thompson Vision, Verana Health and Zeiss; owns stock of Glaukos; has patents and/or royalties with Imprimis. Steven R. Sarkisian Jr is a consultant/advisor for Alcon, Allergan, Bausch + Lomb, Beaver-Visitec International, Glaukos, Icare USA, Katena Products, MicroSurgical Technology, Ocular Science, Santen, and Sight Sciences; is on the speaker’s bureau for Alcon, Allergan, and Bausch + Lomb; has received grant support from Alcon, Allergan, Allysta Pharmaceuticals, Elios, Glaukos, iSTAR Medical, Ocular Science, Ocular Therapeutix, and Sight Sciences; and holds stock or stock options in Ocular Science and Sight Sciences. Lilit A. Voskanyan has received research support from Glaukos. Robert E. Ang has been a speaker for and has received research support from Glaukos. Long V. Doan, David Applegate, Yannan Shen, L. Jay Katz, Angela C. Kothe, and Tomas Navratil are employees of Glaukos Corporation and may have Glaukos stock and/or stock options.

: This study was performed in line with the principles of the Declaration of Helsinki. Approval for the majority of sites was granted by WCG IRB (formerly known as Western Institutional Review Board); approval for single sites each was granted by Wills Eye Hospital Institutional Review Board, St. Cabrini Medical Center-Asian Eye Institute Ethics Review Committee, and the Ethics Committee of Ophthalmological Center named after S.V. Malayan.

: Informed consent was obtained from all individual participants included in the study.

: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

: Not applicable.

: The study was designed by LVD, LJK and DA; data collection was performed by IPS, JPB, SRS, LAV, and REA; statistical analyses were performed by YS; data interpretation was performed by DA, YS, ACK, and TN. Authoring, revisions, and approval of the manuscript: IPS, JPB, SRS, LAV, REA, LVD, DA, YS, LJK, ACK, and TN.